The federal drug pricing program 340B helps hospitals and clinics in Virginia and across the nation care for underserved ...

It's the latest evidence of rising spending in the drug discount program as regulators attempt to tamp down on growth in 340B.

The Department of Health and Human Services is dropping the 340B Rebate Model Pilot but could potentially restart the administrative process for the program, according to a court filing. A federal ...

Hospital drug markups are in the crosshairs as a new proposal targets 340B facilities where a $700 prostate cancer treatment ...

“When a program designed to deliver targeted assistance drives up system-wide costs, reform is no longer optional,” says health expert Sally Pipes. “It's necessary.” If a charity organization ...

The 340B fights of 2026 are being waged as disputes over fairness and intent. Underneath, they are disputes over data.

Arkansas is suing 13 drug manufacturers and related entities, seeking to enforce a state law requiring them to provide ...

The lawsuit, filed in federal court, alleges that since 2020, CVS and its subsidiaries manipulated reimbursements under the ...

A U.S. federal judge has rejected challenges by two pharmaceutical manufacturers seeking to block a Maine law that regulates the use of contract pharmacies under the federal 340B drug discount program ...

A clear look at the 340B program: how hospitals generate revenue from drug discounts, why it has expanded, and the growing policy debate.

In recent weeks, two competing visions have emerged to legislatively modernize the federal 340B drug discount program (“340B Program”).